These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32517872)

  • 1. The impact of medical interventions for reducing ototoxicity during treatment for multi-drug resistant tuberculosis.
    Khoza-Shangase K; Lecheko L; Ntlhakana L
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(6):349-357. PubMed ID: 32517872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An audiological profile of patients infected with multi-drug resistant tuberculosis at a district hospital in KwaZulu-Natal.
    Appana D; Joseph L; Paken J
    S Afr J Commun Disord; 2016 Nov; 63(1):e1-e12. PubMed ID: 28155306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical factors associated with utilisation of ototoxicity monitoring services for multi-drug-resistant tuberculosis patients in the Western Cape.
    Ramma L; Nhokwara PT; Rogers C
    S Afr J Commun Disord; 2019 Jan; 66(1):e1-e6. PubMed ID: 30843411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin.
    Khoza-Shangase K; Prodromos M
    S Afr J Commun Disord; 2021 Jan; 68(1):e1-e8. PubMed ID: 33567829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series.
    Hollander C; Joubert K; Schellack N
    JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14036. PubMed ID: 31934875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal community-based ototoxicity monitoring programme and treatment effects for drug-resistant tuberculosis treatment, Western Cape.
    Stevenson LJ; Biagio-de Jager L; Graham MA; Swanepoel W
    S Afr J Commun Disord; 2022 Mar; 69(1):e1-e13. PubMed ID: 35384675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audiological monitoring of patients undergoing multidrug resistant tuberculosis treatment at Jigme Dorji Wangchuk National Referral Hospital and Gidakom Hospital, Bhutan.
    Wangchuk P; Ram Adhikari T; Nima G; Dendup P
    J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100229. PubMed ID: 33898763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.
    Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
    BMC Womens Health; 2021 Apr; 21(1):164. PubMed ID: 33879158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Are the Current Audiological Practices for Ototoxicity Assessment and Management in the South African Healthcare Context?
    Khoza-Shangase K; Masondo N
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
    Hong H; Dooley KE; Starbird LE; Francis HW; Farley JE
    Arch Toxicol; 2019 May; 93(5):1385-1399. PubMed ID: 30963202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients.
    Harris T; Bardien S; Schaaf HS; Petersen L; De Jong G; Fagan JJ
    S Afr Med J; 2012 May; 102(6 Pt 2):363-6. PubMed ID: 22668907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides.
    Human H; Hagen CM; de Jong G; Harris T; Lombard D; Christiansen M; Bardien S
    Biochem Biophys Res Commun; 2010 Mar; 393(4):751-6. PubMed ID: 20171168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.
    Hong H; Dowdy DW; Dooley KE; Francis HW; Budhathoki C; Han HR; Farley JE
    Int J Tuberc Lung Dis; 2020 Jan; 24(1):65-72. PubMed ID: 32005308
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
    Shibeshi W; Sheth AN; Admasu A; Berha AB; Negash Z; Yimer G
    BMC Pharmacol Toxicol; 2019 May; 20(1):31. PubMed ID: 31122273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The occurrence of auditory dysfunction in children with TB receiving ototoxic medication at a TB hospital in South Africa.
    Ghafari N; Rogers C; Petersen L; Singh SA
    Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1101-5. PubMed ID: 26003627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis.
    Sharma V; Bhagat S; Verma B; Singh R; Singh S
    Iran J Otorhinolaryngol; 2016 May; 28(86):203-8. PubMed ID: 27429949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Hearing Function in Pediatric Patients with Renal Dysfunction: In Pursuit of Preventive Audiology Outcomes.
    Khoza-Shangase K; Lau J
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):4189-4199. PubMed ID: 36742607
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.